Trial Profile
A single dose, cross-over, pharmacokinetic similarity study comparing CHS-0214 with Enbrel in healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 06 Oct 2016 Status changed from active, no longer recruiting to completed.
- 06 Oct 2016 According to a Coherus BioSciences media release, the company anticipates pre-submission meetings in the first quarter 2017.
- 09 May 2015 New trial record